RAF709
a RAF kinase inhibitor with antineoplastic activity; structure in first source
Also Known As:
N-(2-methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-(3,3'-bipyridin)-5-yl)-3-(trifluoromethyl)benzamide
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Amiri, Payman:
2 articles
(01/2018 - 01/2017)
|
| 2. | Cooke, Vesselina G:
2 articles
(01/2018 - 01/2017)
|
| 3. | Dillon, Michael P:
2 articles
(01/2018 - 01/2017)
|
| 4. | Haling, Jacob R:
2 articles
(01/2018 - 01/2017)
|
| 5. | Hekmat-Nejad, Mohammad:
2 articles
(01/2018 - 01/2017)
|
| 6. | Lees, Emma:
2 articles
(01/2018 - 01/2017)
|
| 7. | Mathews Griner, Lesley A:
2 articles
(01/2018 - 01/2017)
|
| 8. | Polyakov, Valery:
2 articles
(01/2018 - 01/2017)
|
| 9. | Ramurthy, Savithri:
2 articles
(01/2018 - 01/2017)
|
| 10. | Rico, Alice:
2 articles
(01/2018 - 01/2017)
|
Related Diseases
Related Drugs and Biologics